Rachelle Jacques
Overview
Rachelle Jacques received an average of $3M in total compensation, including $537K in salary, at Akari Therapeutics Plc between 2022 and 2023.
Source: SEC filing on June 3, 2024.
Related executives
We found six more executives who work or worked at Akari Therapeutics Plc.
Wendy DiCicco
Akari Therapeutics Plc
Chief Financial Officer
Torsten Hombeck
Akari Therapeutics Plc
Chief Financial Officer
Gur Roshwalb
Akari Therapeutics Plc
Chief Executive Officer
Clive Richardson
Akari Therapeutics Plc
Chief Operating Officer
Dov Elefant
Akari Therapeutics Plc
Chief Financial Officer
Pablo Jimenez
Akari Therapeutics Plc